About Deepro R. Mukerjee
Deepro R. Mukerjee is chair of Katten's global Intellectual Property practice and is a member of the firm's Board of Directors. Multi-billion dollar corporations, a major academic institution and some of the largest generic pharmaceutical companies in the world call on Deepro for their respective IP needs – particularly when it comes to complex or high-stakes litigations. Deepro is a first chair litigator, having tried numerous patent trials over his 20-year career. His cases are often featured by media outlets throughout the country.
Intellectual Property Litigation and IP Corporate Transactions
Deepro has been lead trial counsel in dozens of cases, often taking them to trial and subsequent appeals. He is also experienced at managing inter partes review proceedings before the Patent Trial and Appeal Board. While he is often noted for his successes in Hatch-Waxman litigations, Deepro's litigation experience is far more expansive and covers matters related to product manufacturing, biotechnology, botanicals, business methods, web-related services and voice recognition software.
"Deepro is really solution-oriented; he comes up with multiple solutions for you and whichever you select, he helps you execute." "He is a natural leader, a strategic thinker, and an all-around extremely talented litigator." "Deepro is a fantastic attorney, brilliant strategist and a formidable adversary."
Chambers USA 2022
(New York, Intellectual Property: Patent) survey response
Practice Focus
- Hatch-Waxman and bio-similars litigation
- Intellectual property litigation
- Patent litigation
- Corporate IP Counseling
- Medical device and healthcare litigation and counseling
Representative Experience
News
-
November 9, 2022
-
November 1, 2022
-
October 26, 2022
-
August 25, 2022
-
August 22, 2022
-
June 29, 2022
-
June 8, 2022
-
June 3, 2022
-
June 1, 2022
- View All News
Publications
-
July 15, 2022
-
July 12, 2021
-
November 24, 2020
-
August 5, 2020
-
May 19, 2020
-
January 25, 2019
Presentations and Events
-
April 26–27, 2022Speaker | The Business of PIV Disputes — Cross-Border Business Considerations in a Hatch-Waxman Scenario: Masterfully Managing Global Litigation
-
April 26–27, 2021Panelist | The Economics and Economy of Drug Patents with ACI’s Hatch-Waxman Series Advisory Board Members: Optimizing Product Selection, Identifying Targets for Litigation and Monetizing IP Portfolios
-
October 6–7, 2020Panelist | In-House Perspectives on The Future of IP Teams and Working with Outside Counsel